Similar to results found using our laboratory strain, in vitro infection with the clinical isolates resulted in increased protein levels of p-GSK-3β (Ser9) and p-β-catenin (Ser33/37/Thr41) over the time course of infection (Fig. S1A to C). The gene discussed is GSK3B; the disease is infection.